These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12867583)

  • 1. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
    Crilly A; Hamilton J; Clark CJ; Jardine A; Madhok R
    Rheumatology (Oxford); 2003 Nov; 42(11):1295-8. PubMed ID: 12867583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L; Cappiello F; Barili M; Scorza R
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.
    van Bon L; Popa C; Huijbens R; Vonk M; York M; Simms R; Hesselstrand R; Wuttge DM; Lafyatis R; Radstake TR
    Ann Rheum Dis; 2010 Aug; 69(8):1539-47. PubMed ID: 20498209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.
    Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM
    Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation.
    Zheng HX; Burckart GJ; McCurry K; Webber S; Ristich J; Iacono A; Dauber J; McDade K; Grgurich W; Zaldonis D; Pillage G; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 May; 23(5):541-6. PubMed ID: 15135368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 promoter polymorphisms influence disease severity and course in psoriasis.
    Kingo K; Kõks S; Silm H; Vasar E
    Genes Immun; 2003 Sep; 4(6):455-7. PubMed ID: 12944983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.
    Crawley E; Kay R; Sillibourne J; Patel P; Hutchinson I; Woo P
    Arthritis Rheum; 1999 Jun; 42(6):1101-8. PubMed ID: 10366102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.
    Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M
    J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
    Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pupillocynetic activity of substance P in systemic sclerosis.
    Del Rosso A; Bertinotti L; Pietrini U; Messori A; Fanciullacci M; Casale R; Giacomelli R; Generini S; Sicuteri R; Pignone A; Cozzi F; Matucci-Cerinic M
    J Rheumatol; 2003 Jun; 30(6):1231-7. PubMed ID: 12784395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals.
    Kilpinen S; Huhtala H; Hurme M
    Eur Cytokine Netw; 2002; 13(1):66-71. PubMed ID: 11956022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
    Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.
    van der Linden MW; Westendorp RG; Sturk A; Bergman W; Huizinga TW
    J Investig Med; 2000 Sep; 48(5):327-34. PubMed ID: 10979237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.
    Altorok N; Tsou PS; Coit P; Khanna D; Sawalha AH
    Ann Rheum Dis; 2015 Aug; 74(8):1612-20. PubMed ID: 24812288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.